<DOC>
	<DOC>NCT00420342</DOC>
	<brief_summary>The main purpose of this study is to compare the effects of treatment of two different formulations of AngeliqÂ® and Prempro on blood pressure in post-menopausal women with prehypertension.</brief_summary>
	<brief_title>Effects of Angeliq and Prempro on Blood Pressure and Sodium Sensitivity in Postmenopausal Women With Prehypertension</brief_title>
	<detailed_description>This study has previously been posted by Berlex, Inc. Berlex, Inc. has been renamed to Bayer HealthCare Pharmaceuticals, Inc.Bayer HealthCare Pharmaceuticals, Inc. is the sponsor of the trial.</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Prehypertension</mesh_term>
	<mesh_term>Estrogens, Conjugated (USP)</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<mesh_term>Medroxyprogesterone</mesh_term>
	<mesh_term>Medroxyprogesterone Acetate</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<mesh_term>Drospirenone and ethinyl estradiol combination</mesh_term>
	<mesh_term>Drospirenone</mesh_term>
	<criteria>Postmenopausal women 45 65 years old with prehypertension Hormone therapy (estrogen/progestin)</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Pre-Hypertension in Postmenopausal Women</keyword>
</DOC>